Safety and efficacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma - the PriCoTTF phase I/II trial

被引：0

作者：

Kebir, Sied ^{[1
]}

Lazaridis, Lazaros ^{[1
]}

Schmidt, Teresa ^{[1
]}

Oster, Christoph ^{[1
]}

Feldheim, Jonas ^{[1
]}

Proescholdt, Martin ^{[2
]}

Hau, Peter ^{[2
]}

Grosu, Anca Ligia ^{[3
]}

Krex, Dietmar ^{[4
]}

Pierscianek, Daniela ^{[5
]}

Sure, Ulrich ^{[5
]}

Scheffler, Bjoern ^{[6
,7
,8
]}

Kleinschnitz, Christoph ^{[1
]}

Stuschke, Martin ^{[9
]}

Glas, Martin ^{[1
]}

机构：

[1] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Dept Neurol,Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany

[2] Univ Med Ctr Regensburg, Dept Neurosurg, Regensburg, Germany

[3] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany

[4] Univ Hosp Dresden, Dept Neurosurg, Dresden, Germany

[5] Univ Hosp Essen, Dept Neurosurg & Spine Surg, Essen, Germany

[6] Univ Med Essen, West German Canc Ctr WTZ, DKFZ Div Translat Neurooncol, Essen, Germany

[7] German Canc Consortium DKTK, Partner Site, Essen, Germany

[8] German Canc Res Ctr, Essen, Germany

[9] Univ Hosp Essen, Dept Radiotherapy, Essen, Germany

来源：

STRAHLENTHERAPIE UND ONKOLOGIE | 2023年 / 199卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

VS09-1-jD

引用

页码：S32 / S32

页数：1

共 50 条

[21] Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
Stupp, Roger
Hegi, Monika E.
Neyns, Bart
Goldbrunner, Roland
Schlegel, Uwe
Clement, Paul M. J.
Grabenbauer, Gerhard G.
Ochsenbein, Adrian F.
Simon, Matthias
Dietrich, Pierre-Yves
Pietsch, Torsten
Hicking, Christine
Tonn, Joerg-Christian
Diserens, Annie-Claire
Pica, Alessia
Hermisson, Mirjam
Krueger, Stefan
Picard, Martin
Weller, Michael
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2712 - 2718
[22] PHASE I STUDY OF VANDETANIB WITH RADIOTHERAPY AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA
Drappatz, Jan
Norden, Andrew D.
Wong, Eric T.
Doherty, Lisa M.
LaFrankie, Debra C.
Ciampa, Abigail
Kesari, Santosh
Sceppa, Christine
Gerard, Mary
Phan, Phuong
Schiff, David
Batchelor, Tracy T.
Ligon, Keith L.
Young, Geoffrey
Muzikansky, Alona
Weiss, Stephanie E.
Wen, Patrick Y.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (01): : 85 - 90
[23] Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma (INTRAGO): An Open-Label, Dose-Escalation Phase I/II Trial
Giordano, Frank A.
Brehmer, Stefanie
Muerle, Bettina
Welzel, Grit
Sperk, Elena
Keller, Anke
Abo-Madyan, Yasser
Scherzinger, Elisabeth
Clausen, Sven
Schneider, Frank
Herskind, Carsten
Glas, Martin
Seiz-Rosenhagen, Marcel
Groden, Christoph
Haenggi, Daniel
Schmiedek, Peter
Emami, Bahman
Souhami, Luis
Petrecca, Kevin
Wenz, Frederik
NEUROSURGERY, 2019, 84 (01) : 41 - 49
[24] Phase I/IIa trial of autologous formalin-fixed tumor vaccine concomitant with fractionated radiotherapy for newly diagnosed glioblastoma Clinical article
Muragaki, Yoshihiro
Maruyama, Takashi
Iseki, Hiroshi
Tanaka, Masahiko
Shinohara, Chie
Takakura, Kintomo
Tsuboi, Koji
Yamamoto, Tetsuya
Matsumura, Akira
Matsutani, Masao
Karasawa, Katsuyuki
Shimada, Katsunori
Yamaguchi, Naohito
Nakazato, Yoichi
Sato, Keiki
Uemae, Youji
Ohno, Tadao
Okada, Yoshikazu
Hori, Tomokatsu
JOURNAL OF NEUROSURGERY, 2011, 115 (02) : 248 - 255
[25] PHASE I/II TRIAL OF HYPERFRACTIONATED CONCOMITANT BOOST PROTON RADIOTHERAPY FOR SUPRATENTORIAL GLIOBLASTOMA MULTIFORME
Mizumoto, Masashi
Tsuboi, Koji
Igaki, Hiroshi
Yamamoto, Tetsuya
Takano, Shingo
Oshiro, Yoshiko
Hayashi, Yasutaka
Hashii, Haruko
Kanemoto, Ayae
Nakayama, Hidetsugu
Sugahara, Shinji
Sakurai, Hideyuki
Matsumura, Akira
Tokuuye, Koichi
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01): : 98 - 105
[26] EF-32 (TRIDENT): A pivotal phase 3 randomized trial of concomitant radiation therapy and temozolomide plus /- Tumor Treating Fields (TTFields) in newly diagnosed glioblastoma
Glas, M.
Kleinberg, L.
Jeyapalan, S.
Goldlust, S.
Nagpal, S.
Combs, S.
Roberge, D.
Nishikawa, R.
Reardon, D.
Grossman, R.
Shi, W.
STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S97 - S98
[27] PHASE I/II TRIAL OF RADIATION THERAPY, TEMOZOLOMIDE AND PEMBROLIZUMAB FOLLOWED BY TEMOZOLOMIDE AND PEMBROLIZUMAB IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Dixit, Karan
Kumthekar, Priya
Kruser, Timothy
Bloch, Orin
Chandler, James
Tate, Matthew
Raizer, Jeffrey
NEURO-ONCOLOGY, 2016, 18 : 19 - 19
[28] Efficacy and Safety of Tumor Treating Fields (TTFields) in Elderly Patients with Newly Diagnosed Glioblastoma: Subgroup Analysis of the Phase 3 EF-14 Clinical Trial
Ram, Zvi
Kim, Chae-Yong
Hottinger, Andreas F.
Idbaih, Ahmed
Nicholas, Garth
Zhu, Jay-Jiguang
FRONTIERS IN ONCOLOGY, 2021, 11
[29] TUMOR TREATING FIELDS (TTFIELDS) THERAPY WITH CHEMORADIATION, FOLLOWED BY MAINTENANCE TTFIELDS THERAPY/TEMOZOLOMIDE (TMZ), IN NEWLY DIAGNOSED GLIOBLASTOMA (NDGBM). RESULTS OF PHASE II CLINICAL STUDY
Grossman, Rachel
NEURO-ONCOLOGY, 2024, 26
[30] Efficacy and Safety of STUPP Regimen Anlotinib for Newly Diagnosed Glioblastoma: A Multicenter, Double-Blind, Randomized Phase II Trial
Chen, Y.
Liu, G.
Sun, P.
Li, M.
Yang, X.
Pan, L.
Wang, L.
Hua, Y.
Zhao, M.
Liu, Y.
Ran, J.
Cai, H.
Lu, X.
Hao, J.
Li, X.
Zheng, W.
Liu, Z.
Lin, S.
Deng, M.
Yang, Q.
Guo, C.
Li, J.
Chen, Z.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E223 - E224

← 1 2 3 4 5 →